A weekly injection has been found to help obese adults lose up to 52lbs - and reduce their weight by more than 20%. Adults given tirzepatide lost up to 52lbs, according to researchers speaking at the 82nd Scientific Sessions of the American Diabetes Association.
Professor Ania Jastreboff, from Yale University said: “Notably, about nine out of ten individuals with obesity lost weight while taking tirzepatide. Obesity should be treated like any other chronic disease—with effective and safe approaches that target underlying disease mechanisms... These results underscore that tirzepatide may be doing just that."
Professor Sir Stephen O’Rahilly, Director of the Medical Research Council Metabolic Diseases Unit at Cambridge University, said: “The results of this trial are very impressive.
“Treatment of people with obesity with a weekly injection of tirzepatide produced weight loss similar to that seen with weight loss surgery. Side effects were mild to moderate and generally related to some nausea and vomiting. Blood tests showed improvements in all the markers of metabolic and cardiovascular health.
“This study, and recent similar reports of a related agent semaglutide, provide secure evidence that people with obesity can be effectively and safely treated using a medication that is based on the modification of naturally occurring hormones.”
